Dube Peter H, Handley Scott A, Revell Paula A, Miller Virginia L
Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Infect Immun. 2003 Jun;71(6):3512-20. doi: 10.1128/IAI.71.6.3512-3520.2003.
Yersinia enterocolitica is an invasive enteric pathogen that causes significant inflammatory disease. Recently, we identified and characterized a global regulator of virulence (rovA). When mice are infected orally with the rovA mutant they are attenuated by 50% lethal dose (LD(50)) analysis and have altered kinetics of infection. Most significantly, mice orally infected with the rovA mutant have greatly reduced inflammation in the Peyer's patches compared to those infected with wild-type Y. enterocolitica. However, we present data here indicating that when the rovA mutant bacteria are delivered intraperitoneally (i.p.), they are significantly more virulent than when delivered orally. The i.p. LD(50) for the rovA mutant is only 10-fold higher than that of the wild-type Y. enterocolitica, and there are significant inflammatory responses to the rovA mutant that are evident in the liver and spleen. Altogether, these data suggest that the RovA regulon may be required for the early events of the infection that occur in the Peyer's patches. Furthermore, these data suggest that the RovA regulon may be dispensable for Y. enterocolitica systemic disease and inflammatory responses if the Peyer's patches are bypassed.
小肠结肠炎耶尔森菌是一种侵袭性肠道病原体,可引发严重的炎症性疾病。最近,我们鉴定并表征了一种毒力全局调节因子(rovA)。通过50%致死剂量(LD(50))分析发现,当小鼠经口感染rovA突变体时,其毒力减弱,且感染动力学发生改变。最显著的是,与感染野生型小肠结肠炎耶尔森菌的小鼠相比,经口感染rovA突变体的小鼠派尔集合淋巴结中的炎症反应大大减轻。然而,我们在此展示的数据表明,当rovA突变体细菌通过腹腔注射(i.p.)给药时,它们的毒力明显高于经口给药时。rovA突变体的腹腔注射LD(50)仅比野生型小肠结肠炎耶尔森菌高10倍,并且在肝脏和脾脏中对rovA突变体有明显的炎症反应。总之,这些数据表明,RovA调控子可能是派尔集合淋巴结中发生的感染早期事件所必需的。此外,这些数据表明,如果绕过派尔集合淋巴结,RovA调控子对于小肠结肠炎耶尔森菌的全身性疾病和炎症反应可能是可有可无的。